The RSI Oscillator for IRMD moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In 14 of the 16 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 193 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 214 of 265 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRMD as a result. In 71 of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 29 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
IRMD moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.193) is normal, around the industry mean (4.170). P/E Ratio (44.812) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.010) settles around the average of (0.010) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).
The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TCMD as a result. In 72 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 210 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 197 of 234 cases where TCMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 62 cases where TCMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TCMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.508) is normal, around the industry mean (4.170). P/E Ratio (22.734) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
IRMD | TCMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 73 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 22 | 100 | |
SMR RATING 1..100 | 41 | 65 | |
PRICE GROWTH RATING 1..100 | 60 | 54 | |
P/E GROWTH RATING 1..100 | 62 | 60 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TCMD's Valuation (68) in the Medical Specialties industry is in the same range as IRMD (84). This means that TCMD’s stock grew similarly to IRMD’s over the last 12 months.
IRMD's Profit vs Risk Rating (22) in the Medical Specialties industry is significantly better than the same rating for TCMD (100). This means that IRMD’s stock grew significantly faster than TCMD’s over the last 12 months.
IRMD's SMR Rating (41) in the Medical Specialties industry is in the same range as TCMD (65). This means that IRMD’s stock grew similarly to TCMD’s over the last 12 months.
TCMD's Price Growth Rating (54) in the Medical Specialties industry is in the same range as IRMD (60). This means that TCMD’s stock grew similarly to IRMD’s over the last 12 months.
TCMD's P/E Growth Rating (60) in the Medical Specialties industry is in the same range as IRMD (62). This means that TCMD’s stock grew similarly to IRMD’s over the last 12 months.
| IRMD | TCMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | N/A |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 58% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 54% | N/A |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 67% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 73% | 7 days ago 78% |
| Declines ODDS (%) | 8 days ago 60% | 3 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 84% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRMD’s FA Score shows that 1 FA rating(s) are green while TCMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRMD’s TA Score shows that 5 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).
IRMD (@Medical/Nursing Services) experienced а -3.38% price change this week, while TCMD (@Medical/Nursing Services) price change was +5.63% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.01%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -8.84%.
IRMD is expected to report earnings on Feb 04, 2027.
TCMD is expected to report earnings on Feb 23, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.
| Ticker / NAME | Correlation To IRMD | 1D Price Change % | ||
|---|---|---|---|---|
| IRMD | 100% | +2.13% | ||
| HBIO - IRMD | 45% Loosely correlated | +0.81% | ||
| PHG - IRMD | 42% Loosely correlated | +3.15% | ||
| TWST - IRMD | 41% Loosely correlated | +8.73% | ||
| ATEC - IRMD | 40% Loosely correlated | +2.19% | ||
| ICUI - IRMD | 40% Loosely correlated | -0.34% | ||
More | ||||
A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.
| Ticker / NAME | Correlation To TCMD | 1D Price Change % | ||
|---|---|---|---|---|
| TCMD | 100% | +8.35% | ||
| CSTL - TCMD | 50% Loosely correlated | +0.57% | ||
| UFPT - TCMD | 49% Loosely correlated | -1.29% | ||
| AORT - TCMD | 43% Loosely correlated | +0.55% | ||
| GH - TCMD | 38% Loosely correlated | +2.50% | ||
| IRMD - TCMD | 37% Loosely correlated | +2.13% | ||
More | ||||